Vaxcyte Interest Income from 2010 to 2026

PCVX Stock

USD 59.82 2.16 3.48%

Vaxcyte Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income is likely to outpace its year average in 2026. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-03-31

Previous Quarter

29.3 M

Current Value

26.5 M

Quarterly Volatility

13 M

Covid

Interest Hikes

Check Vaxcyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxcyte's main balance sheet or income statement drivers, such as Interest Income of 125.7 M, Depreciation And Amortization of 26.1 M or Interest Expense of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.83. Vaxcyte financial statements analysis is a perfect complement when working with Vaxcyte Valuation or Volatility modules.

Build AI portfolio with Vaxcyte Stock

Check out the analysis of Vaxcyte Correlation against competitors.

For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.

The evolution of Interest Income for Vaxcyte provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Vaxcyte compares to historical norms and industry peers.

Latest Vaxcyte's Interest Income Growth Pattern

Below is the plot of the Interest Income of Vaxcyte over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Vaxcyte's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxcyte's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Vaxcyte Interest Income Regression Statistics

	Arithmetic Mean	25,296,582
	Geometric Mean	1,167,376
	Coefficient Of Variation	185.90
	Mean Deviation	37,310,185
	Median	244,000
	Standard Deviation	47,025,696
	Sample Variance	2211.4T
	Range	125.5M
	R-Value	0.75
	Mean Square Error	1033.4T
	R-Squared	0.56
	Significance	0.0005
	Slope	6,980,765
	Total Sum of Squares	35382.7T

Vaxcyte Interest Income History

	2026	125.7 M
	2025	119.7 M
	2024	110 M
	2023	62.9 M
	2022	8.4 M
	2021	344 K
	2020	244 K

Other Fundumenentals of Vaxcyte

Net Interest Income

Vaxcyte Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Long Term Debt Total	Capital Surpluse	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Invested Capital	Capital Stock	Net Working Capital	Net Receivables	Deferred Long Term Liab
Total Assets		1.0	0.9	-0.13	-0.96	0.93	-0.66	-0.66	0.78	0.86	0.98	0.71	0.88	0.81	-0.61	1.0	0.89	0.92	0.88	0.78
Total Stockholder Equity	1.0		0.9	-0.15	-0.95	0.91	-0.65	-0.65	0.78	0.83	0.98	0.71	0.88	0.8	-0.6	1.0	0.89	0.93	0.86	0.78
Net Tangible Assets	0.9	0.9		-0.43	-0.9	0.82	-0.78	-0.78	0.92	0.76	0.96	0.89	0.93	0.91	-0.75	0.9	0.95	0.92	0.74	0.9
Net Debt	-0.13	-0.15	-0.43		0.02	0.03	0.46	0.46	-0.44	0.09	-0.28	-0.56	-0.42	-0.3	0.5	-0.16	-0.41	-0.41	0.22	-0.38
Retained Earnings	-0.96	-0.95	-0.9	0.02		-0.95	0.66	0.66	-0.79	-0.92	-0.95	-0.7	-0.85	-0.83	0.61	-0.95	-0.86	-0.86	-0.95	-0.78
Accounts Payable	0.93	0.91	0.82	0.03	-0.95		-0.64	-0.64	0.77	0.89	0.89	0.64	0.77	0.7	-0.58	0.92	0.79	0.78	0.95	0.64
Long Term Debt	-0.66	-0.65	-0.78	0.46	0.66	-0.64		1.0	-0.88	-0.66	-0.73	-0.87	-0.81	-0.79	1.0	-0.67	-0.81	-0.71	-0.49	-0.78
Long Term Debt Total	-0.66	-0.65	-0.78	0.46	0.66	-0.64	1.0		-0.88	-0.66	-0.73	-0.87	-0.81	-0.79	1.0	-0.67	-0.81	-0.71	-0.49	-0.78
Capital Surpluse	0.78	0.78	0.92	-0.44	-0.79	0.77	-0.88	-0.88		0.66	0.86	0.97	0.91	0.91	-0.86	0.8	0.92	0.82	0.63	0.89
Total Liab	0.86	0.83	0.76	0.09	-0.92	0.89	-0.66	-0.66	0.66		0.84	0.55	0.7	0.69	-0.6	0.84	0.72	0.71	0.9	0.63
Total Current Assets	0.98	0.98	0.96	-0.28	-0.95	0.89	-0.73	-0.73	0.86	0.84		0.81	0.93	0.86	-0.69	0.98	0.94	0.95	0.83	0.84
Short Term Debt	0.71	0.71	0.89	-0.56	-0.7	0.64	-0.87	-0.87	0.97	0.55	0.81		0.93	0.87	-0.86	0.73	0.93	0.83	0.48	0.89
Common Stock	0.88	0.88	0.93	-0.42	-0.85	0.77	-0.81	-0.81	0.91	0.7	0.93	0.93		0.88	-0.79	0.89	1.0	0.97	0.66	0.92
Property Plant Equipment	0.81	0.8	0.91	-0.3	-0.83	0.7	-0.79	-0.79	0.91	0.69	0.86	0.87	0.88		-0.76	0.81	0.89	0.81	0.67	0.98
Current Deferred Revenue	-0.61	-0.6	-0.75	0.5	0.61	-0.58	1.0	1.0	-0.86	-0.6	-0.69	-0.86	-0.79	-0.76		-0.63	-0.79	-0.69	-0.42	-0.76
Net Invested Capital	1.0	1.0	0.9	-0.16	-0.95	0.92	-0.67	-0.67	0.8	0.84	0.98	0.73	0.89	0.81	-0.63		0.9	0.93	0.86	0.79
Capital Stock	0.89	0.89	0.95	-0.41	-0.86	0.79	-0.81	-0.81	0.92	0.72	0.94	0.93	1.0	0.89	-0.79	0.9		0.97	0.68	0.92
Net Working Capital	0.92	0.93	0.92	-0.41	-0.86	0.78	-0.71	-0.71	0.82	0.71	0.95	0.83	0.97	0.81	-0.69	0.93	0.97		0.68	0.86
Net Receivables	0.88	0.86	0.74	0.22	-0.95	0.95	-0.49	-0.49	0.63	0.9	0.83	0.48	0.66	0.67	-0.42	0.86	0.68	0.68		0.6
Deferred Long Term Liab	0.78	0.78	0.9	-0.38	-0.78	0.64	-0.78	-0.78	0.89	0.63	0.84	0.89	0.92	0.98	-0.76	0.79	0.92	0.86	0.6

Click cells to compare fundamentals

About Vaxcyte Financial Statements

Vaxcyte investors use historical fundamental indicators, such as Vaxcyte's Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaxcyte. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Interest Income	119.7 M	125.7 M
Net Interest Income	119.7 M	125.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Vaxcyte Interest Income from 2010 to 2026

Latest Vaxcyte's Interest Income Growth Pattern

Vaxcyte Interest Income Regression Statistics

Vaxcyte Interest Income History

Other Fundumenentals of Vaxcyte

Vaxcyte Interest Income component correlations

About Vaxcyte Financial Statements

Also Currently Popular

Additional Tools for Vaxcyte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY